07:00 , Jun 20, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Eukaryotic translation elongation factor 2 kinase (EEF2K) Patient, mouse and cell culture studies suggest inhibiting EEF2K could help improve the efficacy of nutrient deprivation...
07:00 , Jun 23, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression Eukaryotic translation elongation factor 2 kinase (EEF2K) Mouse studies suggest decreasing EEF2K activity could help treat depression. In mice, two different EEF2K inhibitors decreased...
07:00 , Apr 23, 2007 |  BioCentury  |  Tools & Techniques

High probability pathways

High probability pathways...